Drug Type AAV based gene therapy |
Synonyms |
Target |
Mechanism A1AT modulators(Alpha-1-antiproteinase modulators), ELA2 inhibitors(Leukocyte elastase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Lexeo Therapeutics, Inc.Startup |
Active Organization Lexeo Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alpha 1-Antitrypsin Deficiency | Discovery | US | Lexeo Therapeutics, Inc.Startup | - |